Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment : Observations From the SAVOR-TIMI 53 Trial
dc.contributor.author | Udell, Jacob A. | |
dc.contributor.author | Bhatt, Deepak L. | |
dc.contributor.author | Braunwald, Eugene | |
dc.contributor.author | Cavender, Matthew A. | |
dc.contributor.author | Mosenzon, Ofri | |
dc.contributor.author | Steg, Gabriel | |
dc.contributor.author | Davidson, Jaime A. | |
dc.contributor.author | Nicolau, Jose C. | |
dc.contributor.author | Corbalán Herreros, Ramón | |
dc.contributor.author | Hirshberg, Boaz | |
dc.contributor.author | Frederich, Robert | |
dc.contributor.author | Im, KyungAh | |
dc.contributor.author | Umez-Eronini, Amarachi A. | |
dc.contributor.author | He, Ping | |
dc.contributor.author | McGuire, Darren K. | |
dc.contributor.author | Leiter, Lawrence A. | |
dc.contributor.author | Raz, Itamar | |
dc.contributor.author | Scirica, Benjamir M. | |
dc.date.accessioned | 2020-08-29T00:35:54Z | |
dc.date.available | 2020-08-29T00:35:54Z | |
dc.date.issued | 2015 | |
dc.format.extent | 10 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.2337/dc14-1850 | |
dc.identifier.eissn | 1935-5548 | |
dc.identifier.issn | 0149-5992 | |
dc.identifier.uri | https://doi.org/10.2337/dc14-1850 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/40544 | |
dc.identifier.wosid | WOS:000351630900035 | |
dc.issue.numero | No. 4 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 705 | |
dc.pagina.inicio | 696 | |
dc.revista | Diabetes Care | es_ES |
dc.rights | acceso abierto | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.other | Diabetes mellitus tipo 2 - Terapia | es_ES |
dc.subject.other | Insuficiencia renal - Terapia | es_ES |
dc.subject.other | Adamantano - Uso terapéutico | es_ES |
dc.subject.other | Enfermedades cardiovasculares | es_ES |
dc.title | Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment : Observations From the SAVOR-TIMI 53 Trial | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 38 | |
sipa.codpersvinculados | 98700 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment Observations From the SAVOR-TIMI 53 Trial.pdf
- Size:
- 1.15 MB
- Format:
- Adobe Portable Document Format
- Description: